Home > Financial Ratios > IPCA LABORATORIES

IPCA LABORATORIES
Core EBITDA Growth

    Back to All Ratios
IPCA LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for IPCA LABORATORIES
Please provide your vote to see the results

IPCA LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 37.28-23.51-14.3564.8429.76

What is the latest Core EBITDA Growth ratio of IPCA LABORATORIES ?

The latest Core EBITDA Growth ratio of IPCA LABORATORIES is 37.28 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202437.28
Mar2023-23.51
Mar2022-14.35
Mar202164.84
Mar202029.76

How is Core EBITDA Growth of IPCA LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2024 37.28
Positive
Mar2023 -23.51
Negative
Mar2022 -14.35
Negative
Mar2021 64.84
117.88
Mar2020 29.76 -

Other Financial Ratios of IPCA LABORATORIES


Compare Core EBITDA Growth ratio of peers of IPCA LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
IPCA LABORATORIES ₹38,212.3 Cr 5.5% -7.7% 23.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,764.0 Cr 0.6% -2.1% 16.5% Stock Analytics
DIVIS LABORATORIES ₹163,010.0 Cr 4.3% 6.5% 63.9% Stock Analytics
CIPLA ₹118,905.0 Cr 3.6% 0.2% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,523.0 Cr 3% -8.4% 0% Stock Analytics
ZYDUS LIFESCIENCES ₹100,015.0 Cr 3.2% -1% 27.4% Stock Analytics


IPCA LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
IPCA LABORATORIES

5.5%

-7.7%

23.7%

SENSEX

0.5%

0.3%

7.9%


You may also like the below Video Courses